Impact of circulating tumor DNA early detection and serial monitoring in the management of stage I to III colorectal cancer
Ann Transl Med
.
2019 Dec;7(Suppl 8):S315.
doi: 10.21037/atm.2019.10.30.
Authors
Diana Bello Roufai
1
,
François-Clément Bidard
1
2
3
Affiliations
1
Department of Medical Oncology, Institut Curie, Saint-Cloud, France.
2
Laboratory of Circulating Tumor Biomarkers, Inserm, Institut Curie, Paris, France.
3
UVSQ, Paris Saclay University, Saint-Cloud, Paris, France.
PMID:
32016033
PMCID:
PMC6976395
DOI:
10.21037/atm.2019.10.30
No abstract available
Publication types
Editorial
Comment